is being presented by Jessica Swartz, Consultant, with IMS Consulting Group and airs on Thursday, October 13th, 2011. For more details or to register for this event, please visit our site at www.fxconferences.com
Neurostimulators are becoming increasingly prevalent in the treatment of a number of serious medical conditions, including Parkinson’s disease, epilepsy, depression and chronic pain. As market opportunities expand, companies are seeking ways to differentiate themselves and increase their clinical reach. This audio conference presentation provides an overview of both current and developmental neuorstimulation devices, and discusses the commercial and clinical significance of these therapies.
Our speaker examines how neurostimulation may affect the clinical management of nervous system disorders in the future, and provides strategic insight into the commercial relevance of these therapies. The presentation also discusses similarities and differences between the various devices, as well as potential opportunities within the neurological stimulator market.
